Gold plays a crucial role in India’s financial ecosystem, with its value closely approaching the country’s GDP. Traditionally viewed as a secure investment and collateral against economic uncertainty, recent gold policy developments indicate a trend towards stability after years of fiscal intervention. The government’s policy over the past decade has focused on reconciling three key…
The Nifty Pharma Index has increased by almost 4%, and Sun Pharma, Gland Pharma, and IPCA Labs have all had gains of nearly 4%. Natco Pharma and Lupin are also making a wise rally. Indian pharmaceutical industries were greatly relieved when US President Donald Trump declared that his tariff policy would spare the pharmaceutical industry….
Ahead of former US President Donald Trump’s tariff deadline, investors were on edge, as the benchmark indices Nifty and Sensex continued to decline on April 1. The sell-off was led by Nifty IT and Pharma, which are the stocks most vulnerable to any trade shocks, and then banking stocks. Fear swept the Street as the…
Telecom operators are probably to soon announce another set of tariff hikes as they look to upgrade their Average Revenue Per User (ARPU) by picking out low-paying, inactive subscribers. The initial concern regarding hiking tariffs seem to have gone as despite the hikes undertaken in December 2021, the active subscriber base of the industry has…
